Genetic Technologies Shares Were Halted on the ASX ‘in Anticipation of an Update Regarding the Company’s COVID-19 Serious Disease Risk Test’
Pursuant to ASX Listing Rule 17.1, Genetic Technologies Limited (NASDAQ: GENE) requests a trading halt in anticipation of an update regarding the Company's COVID-19 Serious Disease Risk Test.